Skip to main content
SpringerLink
Log in

Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography

  • Protocol
  • First Online:
Sirtuins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1077))

Abstract

Nicotinamide adenine dinucleotide (NAD+) plays a critical role in regulating numerous biological and physiological pathways including metabolism, inflammation, cancer, and aging in mammals. Here we describe a highly quantitative method with reverse-phase high-performance liquid chromatography (HPLC) for the determination of NAD+ levels in cells and tissues. This methodology provides accurate, reliable, and reproducible results of NAD+ measurement, which enables us to analyze various pathophysiological changes in NAD+ levels in vitro and in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Belenky P, Bogan KL, Brenner C (2007) NAD + metabolism in health and disease. Trends Biochem Sci 32(1):12–19. doi:10.1016/j.tibs.2006.11.006

    Article  PubMed  CAS  Google Scholar 

  2. Stein LR, Imai S (2012) The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol Metab 23(9):420–428. doi:10.1016/j.tem.2012.06.005

    Article  PubMed  CAS  Google Scholar 

  3. Revollo JR, Grimm AA, Imai S (2007) The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 23(2):164–170. doi:10.1097/MOG.0b013e32801b3c8f

    Article  PubMed  CAS  Google Scholar 

  4. Imai S (2009) The NAD world: a new systemic regulatory network for metabolism and aging–Sirt1, systemic NAD biosynthesis, and their importance. Cell Biochem Biophys 53(2):65–74. doi:10.1007/s12013-008-9041-4

    Article  PubMed  CAS  Google Scholar 

  5. Magni G, Amici A, Emanuelli M, Raffaelli N, Ruggieri S (1999) Enzymology of NAD + synthesis. Adv Enzymol Relat Areas Mol Biol 73:135–182

    PubMed  CAS  Google Scholar 

  6. Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD + precursor vitamins in human nutrition. Annu Rev Nutr 28:115–130. doi:10.1146/annurev.nutr.28.061807.155443

    Article  PubMed  CAS  Google Scholar 

  7. Revollo JR, Grimm AA, Imai S (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49):50754–50763. doi:10.1074/jbc.M408388200

    Article  PubMed  CAS  Google Scholar 

  8. Krishnakumar R, Kraus WL (2010) The PARP side of the nucleus: molecular actions, physiological outcomes, and clinical targets. Mol Cell 39(1):8–24. doi:10.1016/j.molcel.2010.06.017

    Article  PubMed  CAS  Google Scholar 

  9. Bai P, Canto C (2012) The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab 16(3):290–295. doi:10.1016/j.cmet.2012.06.016

    PubMed  CAS  Google Scholar 

  10. Corda D, Di Girolamo M (2003) Functional aspects of protein mono-ADP-ribosylation. EMBO J 22(9):1953–1958. doi:10.1093/emboj/cdg209

    Article  PubMed  CAS  Google Scholar 

  11. Lee HC (2001) Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers. Annu Rev Pharmacol Toxicol 41:317–345. doi:10.1146/annurev.pharmtox.41.1.317

    Article  PubMed  Google Scholar 

  12. Imai S, Guarente L (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 31(5):212–220. doi:10.1016/j.tips.2010.02.003

    Article  PubMed  CAS  Google Scholar 

  13. Guarente L (2011) Franklin H. Epstein lecture: sirtuins, aging, and medicine. N Eng J Med 364(23):2235–2244. doi:10.1056/NEJMra1100831

    Article  CAS  Google Scholar 

  14. Ramsey KM, Yoshino J, Brace CS, Abrassart D, Kobayashi Y, Marcheva B, Hong HK, Chong JL, Buhr ED, Lee C, Takahashi JS, Imai S, Bass J (2009) Circadian clock feedback cycle through NAMPT-mediated NAD + biosynthesis. Science 324(5927):651–654. doi:10.1126/science.1171641

    Article  PubMed  CAS  Google Scholar 

  15. Nakahata Y, Sahar S, Astarita G, Kaluzova M, Sassone-Corsi P (2009) Circadian control of the NAD + salvage pathway by CLOCK-SIRT1. Science 324(5927):654–657. doi:10.1126/science.1170803

    Article  PubMed  CAS  Google Scholar 

  16. Imai S (2010) “Clocks” in the NAD world: NAD as a metabolic oscillator for the regulation of metabolism and aging. Biochim Biophys Acta 1804(8):1584–1590. doi:10.1016/j.bbapap.2009.10.024

    Article  PubMed  CAS  Google Scholar 

  17. Yoshino J, Mills KF, Yoon MJ, Imai S (2011) Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab 14(4):528–536. doi:10.1016/j.cmet.2011.08.014

    Article  PubMed  CAS  Google Scholar 

  18. Revollo JR, Korner A, Mills KF, Satoh A, Wang T, Garten A, Dasgupta B, Sasaki Y, Wolberger C, Townsend RR, Milbrandt J, Kiess W, Imai S (2007) Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6(5):363–375. doi:10.1016/j.cmet.2007.09.003

    Article  PubMed  CAS  Google Scholar 

  19. Bai P, Canto C, Oudart H, Brunyanszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J (2011) PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13(4):461–468. doi:10.1016/j.cmet.2011.03.004

    Article  PubMed  CAS  Google Scholar 

  20. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, Chini EN (2007) The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J 21(13):3629–3639. doi:10.1096/fj.07-8290com

    Article  PubMed  CAS  Google Scholar 

  21. Gillum MP, Erion DM, Shulman GI (2010) Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med. doi:10.1016/j.molmed.2010.09.005

    PubMed  Google Scholar 

  22. Braidy N, Jayasena T, Poljak A, Sachdev PS (2012) Sirtuins in cognitive ageing and Alzheimer’s disease. Curr Opin Psychiatry 25(3):226–230. doi:10.1097/YCO.0b013e32835112c1

    Article  PubMed  Google Scholar 

  23. Donmez G, Wang D, Cohen DE, Guarente L (2010) SIRT1 Suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 142(2):320–332. doi:10.1016/j.cell.2010.06.020

    Article  PubMed  CAS  Google Scholar 

  24. Cohen-Kfir E, Artsi H, Levin A, Abramowitz E, Bajayo A, Gurt I, Zhong L, D’Urso A, Toiber D, Mostoslavsky R, Dresner-Pollak R (2011) Sirt1 is a regulator of bone mass and a repressor of sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 152(12):4514–4524. doi:10.1210/en.2011-1128

    Article  PubMed  CAS  Google Scholar 

  25. Li Y, He X, Li Y, He J, Anderstam B, Andersson G, Lindgren U (2011) Nicotinamide phosphoribosyltransferase (Nampt) affects the lineage fate determination of mesenchymal stem cells: a possible cause for reduced osteogenesis and increased adipogenesis in older individuals. J Bone Miner Res 26(11):2656–2664. doi:10.1002/jbmr.480

    Article  PubMed  CAS  Google Scholar 

  26. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, Teruya-Feldstein J, Moreira PI, Cardoso SM, Clish CB, Pandolfi PP, Haigis MC (2011) SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19(3):416–428. doi:10.1016/j.ccr.2011.02.014

    Article  PubMed  CAS  Google Scholar 

  27. Sebastian C, Zwaans BM, Silberman DM, Gymrek M, Goren A, Zhong L, Ram O, Truelove J, Guimaraes AR, Toiber D, Cosentino C, Greenson JK, Macdonald AI, McGlynn L, Maxwell F, Edwards J, Giacosa S, Guccione E, Weissleder R, Bernstein BE, Regev A, Shiels PG, Lombard DB, Mostoslavsky R (2012) The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151(6):1185–1199. doi:10.1016/j.cell.2012.10.047

    Article  PubMed  CAS  Google Scholar 

  28. Canto C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J (2012) The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab 15(6):838–847. doi:10.1016/j.cmet.2012.04.022

    Article  PubMed  CAS  Google Scholar 

  29. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O’Neil L, White TA, Sinclair DA, Chini EN (2012) Flavonoid apigenin is an inhibitor of the NAD + ase CD38: implications for cellular NAD + metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. doi:10.2337/db12-1139

    PubMed  Google Scholar 

  30. Imai S (2010) A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis. Pharmacol Res 62(1):42–47. doi:10.1016/j.phrs.2010.01.006

    Article  PubMed  CAS  Google Scholar 

  31. Hasmann M, Schemainda I (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63(21): 7436–7442

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Drs. Xuntian Jiang and Daniel Ory for mass spec analysis in the Metabolomics Facility at Washington University School of Medicine. We also thank members of the Imai lab for their critical discussions. This work was supported in part by the National Institute on Aging (AG02150), the Ellison Medical Foundation, and the Longer Life Foundation to S.I. and by institutional support from the Washington University Nutrition Obesity Research Center (P30DK056341) and the Washington University Diabetes Research and Training Center (P60DK020579). S.I. serves as a scientific advisory board member for Sirtris, a GSK company.

Author information

Authors and Affiliations

  1. Center for Human Nutrition, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA

    Jun Yoshino

  2. Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO, USA

    Shin-ichiro Imai

Authors
  1. Jun Yoshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shin-ichiro Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Duke University Medical Center Institute of Molecular Physiology, Durham, North Carolina, USA

    Matthew D. Hirschey

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Yoshino, J., Imai, Si. (2013). Accurate Measurement of Nicotinamide Adenine Dinucleotide (NAD+) with High-Performance Liquid Chromatography. In: Hirschey, M. (eds) Sirtuins. Methods in Molecular Biology, vol 1077. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-637-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-637-5_14

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-636-8

  • Online ISBN: 978-1-62703-637-5

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation